CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
批准号:
2091960
负责人:
MICHAEL B LILLY
金额:
$9.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-01 至 1997-02-28
关键词:
antisense nucleic acid apoptosis biological signal transduction colony stimulating factor cytokine gene expression hematopoietic growth factor myelogenous leukemia neoplasm /cancer immunology phenotype plasmids polymerase chain reaction recombinant proteins tissue /cell culture transfection western blottings
中文摘要
描述:(改编自申请人的摘要)本申请旨在
描述增殖信号通路中的关键步骤
在原始髓系细胞中被GM-CSF激活的相关细胞因子。在…
至少部分髓系白血病可能是由于过度活动所致
这样的信号通路。确定以下方面的关键步骤或唯一步骤
这样的级联可能允许开发药物干预措施来
特别是破坏了这些通路。这一点的具体假设
应用是Pim-1基因工程的表达,全长33kd
丝氨酸/苏氨酸激酶是有效增殖所必需的
通过粒-巨噬细胞集落刺激因子及相关受体传递信号。申请人还进一步
假设Pim-1的表达作为一种特定的指标
激活这些通路。这一假设将由
构建允许过度表达或阻断的细胞系统
Pim-1的活性。依赖因子的髓系细胞株将是
用质粒构建体或逆转录病毒构建体转染以允许
Pim-1基因产物的自主表达。这些株系将
接受不依赖因素的生长、分化障碍、
抑制细胞凋亡和同型聚集。相似的细胞系
将利用含有反义Pim-1结构的质粒来产生
抑制内源性Pim-1基因的活性。这些细胞将是
人粒-巨噬细胞集落刺激因子及其相关细胞因子的反应性研究
有分化的倾向。
英文摘要
DESCRIPTION: (Adapted from applicant's abstract)This application seeks
to characterize critical steps in the proliferative signalling pathways
activated by GM-CSF in related cytokines in primitive myeloid cells. At
least some cases of myeloid leukemia likely result from over activity
of such signal pathways. Identification of critical or unique steps in
such cascades may allow development of pharmacologic interventions to
specifically disrupt these pathways. The specific hypothesis of this
application is that expression of the pim-1 gene project, a 33 kd
serine/threonine kinase, is necessary for effective proliferative
signalling through GM-CSF and related receptors. The applicant further
hypothesizes that pim-1 expression serves as a specific indicator of
activation of such pathways. The hypothesis will be investigated by
constructing cell systems which allow for the over expression or blockade
of pim-1 activity. Factor-dependent myeloid cell lines will be
transfected with plasmid constructs or retroviral constructs to allow
autonomous expression of the pim-1 gene product.These lines will then
be examined for factor- independent growth, impaired differentiation,
inhibition of apoptosis and homotypic aggregation. Similar cell lines
will be created utilizing plasmids containing antisense pim-1 constructs
to inhibit activity of the endogenous pim-1 gene. These cells will be
studied for the responsiveness to GM-CSF and related cytokines and their
propensity to differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase 1 Bioassay-guided Trial of Lycopene and Docetaxel for Prostate Cancer
-
批准号:8723134
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
MUSC/HCC Paul Calabresi Clinical Oncology Training Program Plan
-
批准号:9242567
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
MUSC/HCC Paul Calabresi Clinical Oncology Training Program Plan
-
批准号:8831452
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
Phase 1 Bioassay-guided Trial of Lycopene and Docetaxel for Prostate Cancer
-
批准号:8512436
-
项目类别:
-
资助金额:$20.99万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
MOLECULAR TARGETS OF ANTI-TUMOR NSAIDS
-
批准号:7391006
-
项目类别:
-
资助金额:$3.09万
-
财政年份:2004
-
负责人:MICHAEL B LILLY
-
依托单位:
MOLECULAR TARGETS OF ANTI-TUMOR NSAIDS
-
批准号:6783914
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2004
-
负责人:MICHAEL B LILLY
-
依托单位:
MOLECULAR TARGETS OF ANTI-TUMOR NSAIDS
-
批准号:6892356
-
项目类别:
-
资助金额:$5.01万
-
财政年份:2004
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188842
-
项目类别:
-
资助金额:$4.21万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
-
批准号:2091961
-
项目类别:
-
资助金额:$10.51万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
-
批准号:2091959
-
项目类别:
-
资助金额:$10.19万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188844
-
项目类别:
-
资助金额:$8.8万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
CYTOKINE SIGNALLING IN MYELOID LEUKEMIAS
-
批准号:3509555
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188843
-
项目类别:
-
资助金额:$12.65万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188839
-
项目类别:
-
资助金额:$14.11万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
ASSESSMENT OF HYPERTHERMIA BY IN VIVO NMR SPECTROSCOPY
-
批准号:3177712
-
项目类别:
-
资助金额:$10.89万
-
财政年份:1984
-
负责人:MICHAEL B LILLY
-
依托单位:
ASSESSMENT OF HYPERTHERMIA BY IN VIVO NMR SPECTROSCOPY
-
批准号:3177711
-
项目类别:
-
资助金额:$10.13万
-
财政年份:1984
-
负责人:MICHAEL B LILLY
-
依托单位:
ASSESSMENT OF HYPERTHERMIA BY IN VIVO NMR SPECTROSCOPY
-
批准号:3177710
-
项目类别:
-
资助金额:$10.39万
-
财政年份:1984
-
负责人:MICHAEL B LILLY
-
依托单位:
Murine model of chronic prostatitis
-
批准号:7547700
-
项目类别:
-
资助金额:$1.56万
-
财政年份:--
-
负责人:MICHAEL B LILLY
-
依托单位:
A Phase 1b Trial of Oligomeric Procyanidin Complex in Combination with Metformin for Reduced AGE Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
-
批准号:9419085
-
项目类别:
-
资助金额:$7.45万
-
财政年份:--
-
负责人:MICHAEL B LILLY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: